Plain-language guide to Maryland’s psilocybin, MDMA, and psychedelic laws — what’s legal, what isn’t, and what may change.
Maryland's Psychedelic Substances Task Force released its report in January 2024 recommending a regulated psilocybin services program modeled on Oregon's. HB 0160 (2025) would create such a program. No law has passed as of 2026; psilocybin mushrooms remain Schedule I under state and federal law.
As of 2026, Maryland does not have a licensed psilocybin access program. Legal options for residents include:
No. Psilocybin is a Schedule I controlled substance under Maryland Criminal Law §5-402. No state-level decriminalization has passed. No Maryland city has enacted a deprioritization resolution. Maryland's Psychedelic Substances Task Force released a detailed report in January 2024 recommending a licensed psilocybin services program modeled on Oregon's, but no law has been enacted based on that recommendation.
No, in Maryland. The District of Columbia is a separate jurisdiction where Initiative 81 (2020) made entheogen enforcement the lowest MPDC priority — but that is DC, not Maryland. Baltimore has not passed any psilocybin measure. Maryland suburbs of DC (Bethesda, Silver Spring, College Park) follow Maryland state law.
HB 0160 (2025) would implement the task force recommendation by creating a licensed therapeutic-access program similar to Oregon's Measure 109. If passed, it would require the Maryland Department of Health to establish rules for service centers and facilitators.